Walgreens Boots Alliance Inc. shares are up 1.2% in premarket trades after the drugstore chain reported better-than-expected second-quarter revenue and adjusted earnings, boosted by an improvement in the company's healthcare business.
Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its transition to a private company.
Walgreens reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant prepares to go private. In this article WBA
Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit on Tuesday as the pharmacy chain operator benefited from a turnaround effort that included closing underperforming stores.
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025. Chief Executive Officer Tim Wentworth said: “Second quarter results reflect disciplined cost management and improvement in U.S. Healthcare, which were partially offset by weaker front-end results in U.S. Retail Pha...
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).
Walgreens has agreed to pay $2.8 million to settle allegations that it submitted inflated prices to the Massachusetts and Georgia Medicaid programs for generic medications.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.